Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,378 GBX | +0.49% | +2.05% | +16.66% |
05-13 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
05-13 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.66% | 240B | |
+29.98% | 682B | |
+30.97% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+9.32% | 209B | |
-8.67% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Nanoform Finland Signs Licensing Deal for AI Technology with AstraZeneca